Selicrelumab (anti-CD40),1622140-49-1

Simtuzumab (anti-LOXL2),1318075-13-6

Sotigalimab (anti-CD40),2305607-45-6

Fezakinumab (anti-IL-22),1007106-86-6

Blosozumab (anti-SOST),1132758-87-2

Belantamab (anti-TNFRSF17),2061894-48-0

Otelixizumab (anti-CD3),881191-44-2

Eptinezumab (anti-CGRP),1644539-04-7

Erenumab (anti-CALCRL),1582205-90-0

Canakinumab (anti-IL-1b),914613-48-2

Emicizumab (anti-Factor IX),1610943-06-0

Aprutumab (anti-FGFR2),1634620-63-5

Magrolimab (anti-CD47),2169232-81-7

Vibostolimab (anti-TIGIT),2231305-30-7

Spartalizumab (anti-PD-1),1935694-88-4

4-氨基-3-硝基苯硼酸(含数量不等的酸酐),89466-07-9